Discover
ACAD
ACADIA Pharmaceuticals Inc.
29.41
1 x 28.40
1 x 29.83
bid
ask
+
0.02
0.07%
1 @ 04:00 PM
29.41 +0.00 (0.00%)
| Ytd | 10.11% | |
| 1y | 18.49% |
29.09
day range
29.76
19.69
52 week range
29.76
| Open | 29.58 | Prev Close | 29.39 | Low | 29.09 | High | 29.76 | Mkt Cap | 5.04B |
| Vol | 1.33M | Avg Vol | 1.64M | EPS | 2.06 | P/E | 14.28 | Forward P/E | 32.80 |
| Beta | 0.84 | Short Ratio | 5.90 | Inst. Own | 99.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 24.46 | 200-d Avg | 23.85 | 1yr Est | 33.50 |
| Income Statement | |||
| Total Revenue | 307.96M | ||
| Revenues (USD) | 307.96M | ||
| Cost of Revenue | 28.32M | ||
| Gross Profit | 279.64M | ||
| Operating Expenses | 241.81M | ||
| Research and Development Expense | 81.56M | ||
| Selling, General and Administrative Expense | 160.25M | ||
| Operating Income | 37.84M | ||
| Income Tax Expense | 14.97M | ||
| Net Income | 31.50M | ||
| Net Income Common Stock | 31.50M | ||
| Net Income Common Stock (USD) | 31.50M | ||
| Consolidated Income | 31.50M | ||
| Earnings per Basic Share | 0.18 | ||
| Earnings per Basic Share (USD) | 0.18 | ||
| Earnings per Diluted Share | 0.18 | ||
| Earning Before Interest & Taxes (EBIT) | 46.47M | ||
| Earning Before Interest & Taxes (USD) | 46.47M | ||
| Weighted Average Shares | 171.60M | ||
| Weighted Average Shares Diluted | 172.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 392.83M | ||
| Cash and Equivalents (USD) | 392.83M | ||
| Investments | 571.49M | ||
| Investments Current | 571.49M | ||
| Trade and Non-Trade Receivables | 166.33M | ||
| Current Assets | 1.22B | ||
| Property, Plant & Equipment Net | 86.53M | ||
| Total Assets | 1.74B | ||
| Total Debt | 59.55M | ||
| Current Liabilities | 361.44M | ||
| Debt Non-Current | 59.55M | ||
| Total Liabilities | 436.29M | ||
| Accumulated Retained Earnings (Deficit) | -1.78B | ||
| Accumulated Other Comprehensive Income | -958.00K | ||
| Shareholders Equity | 1.31B | ||
| Shareholders Equity (USD) | 1.31B | ||
| Assets Non-Current | 518.36M | ||
| Total Debt (USD) | 59.55M | ||
| Goodwill and Intangible Assets | 103.45M | ||
| Inventory | 108.67M | ||
| Liabilities Non-Current | 74.86M | ||
| Trade and Non-Trade Payables | 44.57M | ||
| Tax Assets | 240.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.16M | ||
| Net Cash Flow from Financing | 10.49M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 102.77M | ||
| Capital Expenditure | -5.09M | ||
| Issuance (Purchase) of Equity Shares | 10.49M | ||
| Net Cash Flow from Investing | -8.53M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.44M | ||
| Net Cash Flow from Operations | 100.78M | ||
| Effect of Exchange Rate Changes on Cash | 27.00K | ||
| Share Based Compensation | 16.94M | ||